Form 8-K - Current report:
SEC Accession No. 0000950170-23-063347
Filing Date
2023-11-14
Accepted
2023-11-14 07:14:40
Documents
60
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lrmr-20231113.htm   iXBRL 8-K 50125
2 EX-99.1 lrmr-ex99_1.htm EX-99.1 185598
3 EX-99.2 lrmr-ex99_2.htm EX-99.2 49229
4 GRAPHIC img46574298_0.jpg GRAPHIC 282533
5 GRAPHIC img46574298_1.jpg GRAPHIC 282533
6 GRAPHIC lrmr-ex99_2s1.jpg GRAPHIC 217652
7 GRAPHIC lrmr-ex99_2s2.jpg GRAPHIC 773193
8 GRAPHIC lrmr-ex99_2s3.jpg GRAPHIC 518461
9 GRAPHIC lrmr-ex99_2s4.jpg GRAPHIC 490373
10 GRAPHIC lrmr-ex99_2s5.jpg GRAPHIC 437828
11 GRAPHIC lrmr-ex99_2s6.jpg GRAPHIC 498080
12 GRAPHIC lrmr-ex99_2s7.jpg GRAPHIC 389198
13 GRAPHIC lrmr-ex99_2s8.jpg GRAPHIC 369286
14 GRAPHIC lrmr-ex99_2s9.jpg GRAPHIC 438044
15 GRAPHIC lrmr-ex99_2s10.jpg GRAPHIC 371798
16 GRAPHIC lrmr-ex99_2s11.jpg GRAPHIC 458884
17 GRAPHIC lrmr-ex99_2s12.jpg GRAPHIC 339710
18 GRAPHIC lrmr-ex99_2s13.jpg GRAPHIC 368925
19 GRAPHIC lrmr-ex99_2s14.jpg GRAPHIC 534183
20 GRAPHIC lrmr-ex99_2s15.jpg GRAPHIC 398991
21 GRAPHIC lrmr-ex99_2s16.jpg GRAPHIC 413012
22 GRAPHIC lrmr-ex99_2s17.jpg GRAPHIC 473044
23 GRAPHIC lrmr-ex99_2s18.jpg GRAPHIC 361256
24 GRAPHIC lrmr-ex99_2s19.jpg GRAPHIC 517886
25 GRAPHIC lrmr-ex99_2s20.jpg GRAPHIC 215661
26 GRAPHIC lrmr-ex99_2s21.jpg GRAPHIC 201536
27 GRAPHIC lrmr-ex99_2s22.jpg GRAPHIC 389813
28 GRAPHIC lrmr-ex99_2s23.jpg GRAPHIC 291183
29 GRAPHIC lrmr-ex99_2s24.jpg GRAPHIC 144163
30 GRAPHIC lrmr-ex99_2s25.jpg GRAPHIC 390479
31 GRAPHIC lrmr-ex99_2s26.jpg GRAPHIC 426390
32 GRAPHIC lrmr-ex99_2s27.jpg GRAPHIC 375551
33 GRAPHIC lrmr-ex99_2s28.jpg GRAPHIC 349985
34 GRAPHIC lrmr-ex99_2s29.jpg GRAPHIC 355215
35 GRAPHIC lrmr-ex99_2s30.jpg GRAPHIC 330541
36 GRAPHIC lrmr-ex99_2s31.jpg GRAPHIC 241766
37 GRAPHIC lrmr-ex99_2s32.jpg GRAPHIC 149530
38 GRAPHIC lrmr-ex99_2s33.jpg GRAPHIC 459114
39 GRAPHIC lrmr-ex99_2s34.jpg GRAPHIC 348801
40 GRAPHIC lrmr-ex99_2s35.jpg GRAPHIC 368654
41 GRAPHIC lrmr-ex99_2s36.jpg GRAPHIC 318211
42 GRAPHIC lrmr-ex99_2s37.jpg GRAPHIC 287598
43 GRAPHIC lrmr-ex99_2s38.jpg GRAPHIC 385098
44 GRAPHIC lrmr-ex99_2s39.jpg GRAPHIC 138947
45 GRAPHIC lrmr-ex99_2s40.jpg GRAPHIC 343317
46 GRAPHIC lrmr-ex99_2s41.jpg GRAPHIC 258190
47 GRAPHIC lrmr-ex99_2s42.jpg GRAPHIC 373014
48 GRAPHIC lrmr-ex99_2s43.jpg GRAPHIC 339010
49 GRAPHIC lrmr-ex99_2s44.jpg GRAPHIC 304855
  Complete submission text file 0000950170-23-063347.txt   23407017

Data Files

Seq Description Document Type Size
50 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lrmr-20231113.xsd EX-101.SCH 2472
51 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lrmr-20231113_lab.xml EX-101.LAB 12806
52 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lrmr-20231113_pre.xml EX-101.PRE 9455
54 EXTRACTED XBRL INSTANCE DOCUMENT lrmr-20231113_htm.xml XML 4533
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 231401556
SIC: 2834 Pharmaceutical Preparations